R. Snow, C. Guerra, A. Noor, H. Myint, and S. Hay, The global distribution of clinical episodes of Plasmodium falciparum malaria, Nature, vol.3, issue.7030, pp.214-217, 2005.
DOI : 10.1016/S0169-4758(98)01296-4

K. Marsh, D. Forster, C. Waruiru, I. Mwangi, M. Winstanley et al., Indicators of Life-Threatening Malaria in African Children, New England Journal of Medicine, vol.332, issue.21, pp.1399-1404, 1995.
DOI : 10.1056/NEJM199505253322102

A. Dondorp, F. Nosten, K. Stepniewska, N. Day, and N. White, Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial, Lancet, vol.366, pp.717-725, 2005.

R. Idro, N. Jenkins, and C. Newton, Pathogenesis, clinical features, and neurological outcome of cerebral malaria, The Lancet Neurology, vol.4, issue.12, pp.827-840, 2005.
DOI : 10.1016/S1474-4422(05)70247-7

H. Van-der-heyde, J. Nolan, V. Combes, I. Gramaglia, and G. Grau, A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction, Trends in Parasitology, vol.22, issue.11, pp.503-508, 2006.
DOI : 10.1016/j.pt.2006.09.002

M. Ho and N. White, Molecular mechanisms of cytoadherence in malaria, Am J Physiol, vol.276, pp.1231-1242, 1999.

N. Jenkins, Y. Wu, S. Chakravorty, K. O. Marsh, K. Craig et al., Intercellular Adhesion Molecule???1???Based Cytoadherence???Related Signaling in Human Endothelial Cells, The Journal of Infectious Diseases, vol.196, issue.2, pp.321-327, 2007.
DOI : 10.1086/518795

P. Pino, I. Vouldoukis, J. Kolb, N. Mahmoudi, I. Desportes-livage et al., ???Infected Erythrocyte Adhesion Induces Caspase Activation and Apoptosis in Human Endothelial Cells, The Journal of Infectious Diseases, vol.187, issue.8, pp.1283-1290, 2003.
DOI : 10.1086/373992

A. Tripathi, W. Sha, V. Shulaev, M. Stins, D. Sullivan et al., Plasmodium falciparum-infected erythrocytes induce NF-??B regulated inflammatory pathways in human cerebral endothelium, Blood, vol.114, issue.19, pp.4243-4252, 2009.
DOI : 10.1182/blood-2009-06-226415

P. Pino, I. Vouldoukis, N. Dugas, G. Hassani-loppion, B. Dugas et al., -Infected Erythrocytes, Annals of the New York Academy of Sciences, vol.12, issue.1, pp.582-586, 2003.
DOI : 10.1196/annals.1299.109

URL : https://hal.archives-ouvertes.fr/hal-01009683

Z. Taoufiq, F. Gay, J. Balvanyos, L. Ciceron, M. Tefit et al., Rho Kinase Inhibition in Severe Malaria: Thwarting Parasite???Induced Collateral Damage to Endothelia, The Journal of Infectious Diseases, vol.197, issue.7, pp.1062-1073, 2008.
DOI : 10.1086/528988

A. Tripathi, D. Sullivan, and M. Stins, ???Infected Erythrocytes Decrease the Integrity of Human Blood???Brain Barrier Endothelial Cell Monolayers, The Journal of Infectious Diseases, vol.195, issue.7, pp.942-950, 2007.
DOI : 10.1086/512083

Z. Taoufiq, P. Pino, N. Dugas, M. Conti, M. Tefit et al., Transient supplementation of superoxide dismutase protects endothelial cells against Plasmodium falciparum-induced oxidative stress, Molecular and Biochemical Parasitology, vol.150, issue.2, pp.166-173, 2006.
DOI : 10.1016/j.molbiopara.2006.07.008

U. Laufs, Beyond lipid-lowering: effects of statins on endothelial nitric oxide, European Journal of Clinical Pharmacology, vol.104, issue.11, pp.719-731, 2003.
DOI : 10.1172/JCI200114453

R. Rosenson, Pluripotential Mechanisms of Cardioprotection with HMG-CoA Reductase Inhibitor Therapy, American Journal of Cardiovascular Drugs, vol.18, issue.2, pp.411-420, 2001.
DOI : 10.2165/00129784-200101060-00001

A. Brouet, P. Sonveaux, C. Dessy, S. Moniotte, J. Balligand et al., Hsp90 and Caveolin Are Key Targets for the Proangiogenic Nitric Oxide-Mediated Effects of Statins, Circulation Research, vol.89, issue.10, pp.866-873, 2001.
DOI : 10.1161/hh2201.100319

D. Sumi, T. Hayashi, N. Thakur, M. Jayachandran, Y. Asai et al., A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects ??? the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action, Atherosclerosis, vol.155, issue.2, pp.347-357, 2001.
DOI : 10.1016/S0021-9150(00)00597-9

M. Romano, L. Diomede, M. Sironi, L. Massimiliano, M. Sottocorno et al., Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins, Laboratory Investigation, vol.55, issue.7, pp.1095-1100, 2000.
DOI : 10.1016/S0140-6736(96)05190-2

C. Urbich, E. Dernbach, A. Zeiher, and S. Dimmeler, Double-Edged Role of Statins in Angiogenesis Signaling, Circulation Research, vol.90, issue.6, pp.737-744, 2002.
DOI : 10.1161/01.RES.0000014081.30867.F8

A. Siau, F. Toure, O. Ouwe-missi-oukem-boyer, L. Ciceron, N. Mahmoudi et al., Field Isolates: Identification of New Pathogenicity Factors, The Journal of Infectious Diseases, vol.196, issue.11, pp.1603-1612, 2007.
DOI : 10.1086/522012

E. Zang-edou, U. Bisvigou, Z. Taoufiq, F. Lekoulou, J. Lekana-douki et al., Inhibition of Plasmodium falciparum Field Isolates-Mediated Endothelial Cell Apoptosis by Fasudil: Therapeutic Implications for Severe Malaria, PLoS ONE, vol.5, issue.2, p.13221, 2010.
DOI : 10.1371/journal.pone.0013221.t002

S. Mishra, S. Mohanty, A. Mohanty, and B. Das, Management of severe and complicated malaria, J Postgrad Med, vol.52, pp.281-287, 2006.

K. Muanza, F. Gay, C. Behr, and A. Scherf, Primary culture of human lung microvessel endothelial cells : A useful in vitro model for studying Plasmodium falciparum-infected erythrocyte cytoadherence, Research in Immunology, vol.147, issue.3, pp.149-163, 1996.
DOI : 10.1016/0923-2494(96)83167-1

W. Trager, CULTIVATION OF MALARIA PARASITES, British Medical Bulletin, vol.38, issue.2, pp.7-26, 1994.
DOI : 10.1093/oxfordjournals.bmb.a071748

I. Goodyer, J. Johnson, R. Eisenthal, and D. Hayes, by gelatine flotation, Annals of Tropical Medicine & Parasitology, vol.27, issue.2, pp.209-211, 1994.
DOI : 10.1080/00034983.1978.11719283

M. Brun, S. Bourdoulous, P. Couraud, J. Elion, R. Krishnamoorthy et al., Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells, The Pharmacogenomics Journal, vol.3, issue.4, pp.215-226, 2003.
DOI : 10.1038/sj.tpj.6500176

A. Tripathi, D. Sullivan, and M. Stins, Plasmodium falciparum-Infected Erythrocytes Increase Intercellular Adhesion Molecule 1 Expression on Brain Endothelium through NF-??B, Infection and Immunity, vol.74, issue.6, pp.3262-3270, 2006.
DOI : 10.1128/IAI.01625-05

J. Mason, Statins and their role in vascular protection, Clinical Science, vol.105, issue.3, pp.251-266, 2003.
DOI : 10.1042/CS20030148

S. Wolfrum, K. Jensen, and J. Liao, Endothelium-Dependent Effects of Statins, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.5, pp.729-736, 2003.
DOI : 10.1161/01.ATV.0000063385.12476.A7

L. Schofield, S. Novakovic, P. Gerold, R. Schwarz, M. Mcconville et al., Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction, J Immunol, vol.156, pp.1886-1896, 1996.

S. Datta, H. Dudek, X. Tao, S. Masters, H. Fu et al., Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery, Cell, vol.91, issue.2, pp.231-241, 1997.
DOI : 10.1016/S0092-8674(00)80405-5

M. Endres, U. Laufs, J. Liao, and M. Moskowitz, Targeting eNOS for stroke protection, Trends in Neurosciences, vol.27, issue.5, pp.283-289, 2004.
DOI : 10.1016/j.tins.2004.03.009

P. Sobolewski, I. Gramaglia, J. Frangos, M. Intaglietta, and H. Van-der-heyde, Nitric oxide bioavailability in malaria, Trends in Parasitology, vol.21, issue.9, pp.415-422, 2005.
DOI : 10.1016/j.pt.2005.07.002

A. Couto, E. Kimura, V. Peres, M. Uhrig, and A. Katzin, Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units, Biochemical Journal, vol.341, issue.3, pp.629-637, 1999.
DOI : 10.1042/0264-6021:3410629

B. Pradines, M. Torrentino-madamet, A. Fontaine, M. Henry, E. Baret et al., Atorvastatin Is 10-Fold More Active In Vitro than Other Statins against Plasmodium falciparum, Antimicrobial Agents and Chemotherapy, vol.51, issue.7, pp.2654-2655, 2007.
DOI : 10.1128/AAC.01330-06

V. Parquet, S. Briolant, M. Torrentino-madamet, M. Henry, L. Almeras et al., Atorvastatin Is a Promising Partner for Antimalarial Drugs in Treatment of Plasmodium falciparum Malaria, Antimicrobial Agents and Chemotherapy, vol.53, issue.6, pp.2248-2252, 2009.
DOI : 10.1128/AAC.01462-08

A. Helmers, D. Gowda, K. Kain, and W. Liles, Statins Fail to Improve Outcome in Experimental Cerebral Malaria and Potentiate Toll-Like Receptor-Mediated Cytokine Production by Murine Macrophages, American Journal of Tropical Medicine and Hygiene, vol.81, issue.4, pp.631-637, 2009.
DOI : 10.4269/ajtmh.2009.09-0204

R. Kobbe, N. Schreiber, M. J. Jacobs, and T. , Simvastatin Treatment Shows No Effect on the Incidence of Cerebral Malaria or Parasitemia during Experimental Malaria, Antimicrobial Agents and Chemotherapy, vol.52, issue.4, pp.1583-1584, 2008.
DOI : 10.1128/AAC.01428-07

A. Bienvenu and S. Picot, Statins Alone Are Ineffective in Cerebral Malaria but Potentiate Artesunate, Antimicrobial Agents and Chemotherapy, vol.52, issue.11, pp.4203-4204, 2008.
DOI : 10.1128/AAC.00513-08

V. Parquet, M. Henry, N. Wurtz, J. Dormoi, S. Briolant et al., Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum, Malaria Journal, vol.9, issue.1, p.139, 2010.
DOI : 10.1186/1475-2875-9-139

H. Savini, J. Souraud, S. Briolant, E. Baret, R. Amalvict et al., Atorvastatin as a Potential Antimalarial Drug: In Vitro Synergy in Combinational Therapy with Dihydroartemisinin, Antimicrobial Agents and Chemotherapy, vol.54, issue.2, pp.966-967, 2010.
DOI : 10.1128/AAC.01006-09

N. Wurtz, S. Briolant, M. Gil, V. Parquet, M. Henry et al., Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene, Journal of Antimicrobial Chemotherapy, vol.65, issue.7, pp.1387-1394, 2010.
DOI : 10.1093/jac/dkq173

P. Lackner, R. Beer, R. Helbok, G. Broessner, K. Engelhardt et al., Scanning electron microscopy of the neuropathology of murine cerebral malaria, Malaria Journal, vol.5, issue.1, p.116, 2006.
DOI : 10.1186/1475-2875-5-116

N. White, G. Turner, I. Medana, A. Dondorp, and N. Day, The murine cerebral malaria phenomenon, Trends in Parasitology, vol.26, issue.1, pp.11-15, 2009.
DOI : 10.1016/j.pt.2009.10.007

Q. Zhou and J. Liao, Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy, Current Pharmaceutical Design, vol.15, issue.5, pp.467-478, 2009.
DOI : 10.2174/138161209787315684

M. Bhf, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebocontrolled trial, Lancet, vol.360, pp.7-22, 2002.

O. Driscoll, G. Green, D. Taylor, and R. , Simvastatin, an HMG??Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month, Circulation, vol.95, issue.5, pp.1126-1131, 1997.
DOI : 10.1161/01.CIR.95.5.1126

J. Goldstein and M. Brown, Regulation of the mevalonate pathway, Nature, vol.343, issue.6257, pp.425-430, 1990.
DOI : 10.1038/343425a0

L. Van-aelst, D. Souza-schorey, and C. , Rho GTPases and signaling networks, Genes & Development, vol.11, issue.18, pp.2295-2322, 1997.
DOI : 10.1101/gad.11.18.2295

J. Waknine-grinberg, J. Mcquillan, N. Hunt, H. Ginsburg, and J. Golenser, Modulation of cerebral malaria by fasudil and other immune-modifying compounds, Experimental Parasitology, vol.125, issue.2, pp.141-146, 2010.
DOI : 10.1016/j.exppara.2010.01.005